Dorsey Wright & Associates Harrow Health, Inc. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$13.84 - $21.46 $3,612 - $5,601	-261 Reduced 10.04%	2,339 $49,000
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $26,728 - $38,428	2,600 New	2,600 $38,000
Q2 2019 Jul 02, 2019	SELL	$4.2 - $8.7 $5,913 - $12,249	-1,408 Closed	0 $0
Q1 2019 Apr 04, 2019	BUY	$4.75 - $7.1 $6,688 - $9,996	1,408 New	1,408 $7,000

176

21.3M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $885M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.